Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Virios Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-KS-1/A
Revenues  0.00.00.00.80.0
            Revenue growth    -100.0%  
Cost of goods sold  0.00.00.02.20.0
Gross profit  0.00.00.0-1.40.0
            Gross margin     -172.1% 
Selling, general and administrative   [+]4.24.89.81.41,107.4
Research and development  8.110.80.2 854.1
Other operating expenses     -0.6 
EBIT   [+]-12.3-15.6-10.0-2.2-1,961.5
            EBIT margin     -272.1% 
Interest expense, net   [+]-0.10.00.40.3152.1
Other income (expense), net   [+] -0.30.0 0.0
Pre-tax income  -12.2-16.0-10.3-2.5-2,113.6
Income taxes  0.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%
Net income  -12.2-16.0-10.3-2.5-2,113.6
            Net margin     -309.0% 
   
Basic EPS   [+]($1.11)($1.92)($2.10)($0.51) 
Diluted EPS   [+]($1.11)($1.92)($2.10)($0.51) 
   
Shares outstanding (basic)   [+]11.18.34.94.8 
Shares outstanding (diluted)   [+]11.18.34.94.8 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy